1      1

2019 Nephrology Nursing Practice, Management, & Leadership Conference

312 - Changes through Stages: Chronic Kidney Disease Stage 3


Oct 14, 2019 7:30am ‐ Oct 14, 2019 9:00am



Credits: None available.

Members: $30.00
Standard: $40.00

Description

This session provides an overview of stage 3 chronic kidney disease, including the disease manifestations, medical and nursing interventions, strategies to delay progression, and tools and resources available for patient care.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/14/2021.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee:

Marijo Johnson - Employee, Fresenius Medical Care

Speaker: 
Molly Cahill - Speaker, Amgen; Consultant, Braun; Partner, DaVita Joint Ventures

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

Learning Outcome:
After completing this learning activity, the learner will describe manifestations of CKD stage 3, medical and nursing interventions for treatment, and education to slow progression of the disease process.

Speaker(s):

  • Molly L. Cahill, MSN, NP-C, APRN, BC, CNN, FNKF, Nurse Practitioner, KC Kidney Consultants

Credits Available


You must be logged in and own this session in order to post comments.